Record overview
Status and phase
Status: WITHDRAWN
Phase: PHASE2
Sponsor: MedSIR
Condition: Non-small Cell Lung Cancer
NCT06676917
Datopotamab Deruxtecan (Dato-DXd) for Non-Small Cell Lung Cancer (NSCLC) Patients With Active Brain Metastases
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: None
Results signal: Low Signal
Operational burden: rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
The clinical trial has not been approved by the regulatory authority.